Navigation Links
Emerging HIV epidemics among people who inject drugs in the Middle East and North Africa
Date:6/19/2014

DOHA, QATAR (June 17, 2014) -- HIV epidemics are emerging among people who inject drugs in several countries in the Middle East and North Africa. Though HIV infection levels were historically very low in the Middle East and North Africa, substantial levels of HIV transmission and emerging HIV epidemics have been documented among people who inject drugs in at least one-third of the countries of this region, according to findings published today in PLOS Medicine.

The HIV epidemics among people who inject drugs (PWID) are recent overall, starting largely around 2003 and continuing to grow in most countries. However, they vary across the region. In countries such as Afghanistan, Bahrain, Egypt, Iran, Morocco, Oman, and Pakistan, on average between 10 and 15 percent of PWID are HIV-positive. The HIV epidemics in these countries appear to be growing; in Pakistan, for example, the fraction of PWID who are HIV-infected increased from 11 percent in 2005 to 25 percent in 2011. In Iran, the HIV epidemic among PWID has stabilized at about 15 percent. There are, however, other countries where limited HIV transmission was found among PWID, such as in Jordan, Lebanon, Palestine and Syria.

"Not only have we found a pattern of new HIV epidemics among PWID in the region, but we found also indications that there could be hidden HIV epidemics among this marginalized population in several countries with still-limited data," said Ghina Mumtaz, lead author of the study and senior epidemiologist at the Infectious Disease Epidemiology Group at Weill Cornell Medical College-Qatar. "For example in Libya, the first study among people who inject drugs was conducted only recently and unveiled alarmingly high levels of HIV infection, suggesting that the virus has been propagating, unnoticed, among this population for at least a decade. Eighty-seven percent of PWID in Tripoli, the capital of Libya, were infected with HIV, one of the highest levels reported among PWID globally."

The study estimated that there are about 626,000 people who inject drugs in the Middle East and North Africa. This translates into 24 people who inject drugs for every 1,000 adults in this part of the world. These individuals are typically involved in several types of behavior that expose them to HIV infection, such as sharing of needles or syringes, a behavior reported by 18 to 28 percent of injecting drug users during their last injection across these countries.

"The levels of HIV infection among people who inject drugs tell only half of the story. We also see high levels of risky practices that will likely expose this population to further HIV transmission in the coming years," said Dr. Laith Abu-Raddad, principal investigator of the study and associate professor of public health in the Infectious Disease Epidemiology Group at Weill Cornell Medical College-Qatar. "We found that nearly half of people who inject drugs are infected with hepatitis C virus, another infection of concern that is also transmitted though sharing of needles and syringes."

"Since the HIV epidemics among people who inject drugs in the Middle East and North Africa are still overall in an early phase, there is a window of opportunity to prevent these epidemics from further growth. This will also limit the potential for HIV transmission to be bridged to other population groups," Mumtaz said.

Although the region overall lags behind in responding to the emerging HIV epidemics among PWID, several countries have made significant progress in building and expanding harm-reduction programs and integrating them within the socio-cultural fabric of the region. These programs refer to policies and strategies aimed at reducing the harmful consequences of injecting drug use, including needle- and syringe-exchange programs and opioid-substitution therapies.

"It is of priority that countries in the region expand HIV surveillance systems among PWID to detect and monitor these budding and growing HIV epidemics. About half of the countries of the region still lack sufficient data to assess the levels of HIV infection among this population, and we continue to discover these epidemics several years after their onset. We need to be ahead of the epidemic to prevent a public health burden that this region is largely not prepared to handle," Dr. Abu-Raddad said.


'/>"/>

Contact: Ashley Paskalis
asp2011@med.cornell.edu
646-317-7378
Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
2. CDC Warns of Another Emerging Tick-Borne Threat
3. New Immune-Deficiency Illness Emerging in East Asia
4. Expanding database enables discoveries in emerging field of metabolomics
5. CWRUs Maxwell J. Mehlmans book examines issues emerging in genetic engineering
6. Queens scientist is named Emerging Scientist 2012
7. Chicago Hat Designer Tonya Gross Selected by Online Retailer Zappos.com for 2013 Emerging Designer Program
8. NIH scientists reflect on gains in emerging infectious disease awareness, research and response
9. Emerging cancer drugs may drive bone tumors
10. OLEV selected as 1 of 10 emerging technologies in 2013 by World Economic Forum
11. Emerging SARS-Like Virus Well-Suited to Attack Humans: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO ... found in power plant water and steam. , Chlorides and sulfates cause pitting ... leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... and TORONTO , March 28, 2017 ... leading full service medical device development firm, announced today ... Toronto -based medical device industrial design ... serve medtech companies throughout North America ... experienced medical device talent spanning the design, engineering, regulatory, ...
(Date:3/28/2017)... United Kingdom and  BOSTON , March 28, ... Linguamatics today announced a partnership with ... The agreement allows pharmaceutical companies to extract key ... I2E text mining technology. The ... of the top 20 global pharmaceutical companies. The ...
(Date:3/28/2017)... , March 28, 2017 Emosis SAS, ... new business entity, Emosis Ltd, headquartered in Tel Aviv ... novel assays complementing the mother company existing technology platform and test ... sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. Emosis ...
Breaking Medicine Technology: